By Ernie Mundell and Robin Foster HealthDay Reporters FRIDAY, July 9, 2021 — Pfizer and its partner BioNTech announced Thursday they would seek approval for a booster COVID-19 shot and begin studies on a reformulated vaccine that targets the highly contagious Delta variant. “We continue to believe that it is likely, based on the totality… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
FORT LAUDERDALE, Fla. — A cruise ship that has been floating at sea with coronavirus patients aboard for two weeks after being turned away from South American ports was finally allowed to dock in Florida on Thursday. The Zaandam and a sister ship sent to help it, the Rotterdam, were both given permission to disembark… Read More »
Value-based care platform provider Apervita says it is the first company to be certified by the National Committee for Quality Assurance for electronic clinical quality measures using a clinical quality language-based engine. The company’s newly certified CQL-based engine—based on HL7 logic standards that support both eCQMs and clinical decision support—can be adopted by healthcare organizations… Read More »
Print this page PARSIPPANY, N.J.–(BUSINESS WIRE) January 28, 2020 — Teva Pharmaceuticals USA, Inc. an affiliate ofTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) has approved an autoinjector device for Ajovy® (fremanezumab-vfrm) injection. “The approval of the Ajovy autoinjector is another important step forward for Teva… Read More »
Historically, metastatic bladder cancer has been “a very bad prognosis,” in the words of Seattle Genetics CEO Clay Siegall. But his company and partner Astellas now have a shot at trying to change that. Wednesday, the FDA handed the duo an early approval for Padcev, a first-of-its kind antibody drug conjugate. The product targets Nectin-4, a protein… Read More »
End-stage renal disease (ESRD) patients experiencing kidney failure typically require hemodialysis in order to artificially remove fluid and waste from blood and maintain appropriate electrolyte concentrations. For many patients on hemodialysis, an arteriovenous (AV) fistula is created to link an artery to a vein. Veins are too fragile for frequent access, but arteries are too… Read More »